Advertisement
Canada markets close in 4 hours 57 minutes

  • S&P/TSX

    21,946.69
    +61.31 (+0.28%)
     

  • S&P 500

    5,110.53
    +62.11 (+1.23%)
     

  • DOW

    38,252.71
    +166.91 (+0.44%)
     

  • CAD/USD

    0.7308
    -0.0015 (-0.20%)
     

  • CRUDE OIL

    83.52
    -0.05 (-0.06%)
     

  • Bitcoin CAD

    87,540.73
    +719.37 (+0.83%)
     

  • CMC Crypto 200

    1,330.38
    -66.15 (-4.74%)
     

  • GOLD FUTURES

    2,343.30
    +0.80 (+0.03%)
     

  • RUSSELL 2000

    1,998.61
    +17.49 (+0.88%)
     

  • 10-Yr Bond

    4.6630
    -0.0430 (-0.91%)
     

  • NASDAQ

    15,966.88
    +355.12 (+2.27%)
     

  • VOLATILITY

    15.33
    -0.04 (-0.26%)
     

  • FTSE

    8,139.67
    +60.81 (+0.75%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6839
    +0.0018 (+0.26%)
     
MARKETS LIVE BLOG:

STOCKS RISE, LED BY STELLAR ALPHABET, MICROSOFT EARNINGS

Results from 'Magnificent Seven' duo show cloud revenue boosted by strong AI demand

Today’s Research Reports on RNC Minerals, Delivra, The Hydropothecary and VentriPoint Diagnostics

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / March 28, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI has Initiated Coverage Today on:

RNC Minerals
https://rdinvesting.com/news/?ticker=RNX.TO

Delivra Corp.
https://rdinvesting.com/news/?ticker=DVA.V

The Hydropothecary Corp.
https://rdinvesting.com/news/?ticker=THCX.V

VentriPoint Diagnostics Ltd.
https://rdinvesting.com/news/?ticker=VPT.V

ADVERTISEMENT

RNC Minerals' stock moved 7.41% lower Tuesday, to close the day at $0.25. The stock recorded a trading volume of 1,183,513 shares, which was below its three months average volume of 1,851,043 shares. In the last year, RNC Minerals’ shares have traded in a range of 0.16 - 0.38. The share price has gained 56.25% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.26 is greater than its 200-day moving average of $0.21. Shares of RNC Minerals have gained approximately 38.89 percent year-to-date.

Access RDI’s RNC Minerals Research Report at:
https://rdinvesting.com/news/?ticker=RNX.TO

On Tuesday, shares of Delivra recorded a trading volume of 9,553 shares, which was below the three months average volume of 87,886 shares. The stock ended the day 5.71% lower at 0.33. The stock is currently trading 44.07% below its 52-week high with a 52-week trading range of 0.33 - 0.59. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.39 is below its 200-day moving average of $0.42. Shares of Delivra have fallen approximately 26.67 percent year-to-date.

Access RDI’s Delivra Corp. Research Report at:
https://rdinvesting.com/news/?ticker=DVA.V

The Hydropothecary 's stock moved 6.57% lower Tuesday, to close the day at $3.98. The stock recorded a trading volume of 1,984,718 shares, which was below its three months average volume of 2,825,833 shares. In the last year, The Hydropothecary 's shares have traded in a range of 1.10 - 13.80. The share price has gained 261.82% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $3.93 is greater than its 200-day moving average of $3.17. Shares of The Hydropothecary have fallen approximately 2.69 percent year-to-date.

Access RDI’s The Hydropothecary Corp. Research Report at:
https://rdinvesting.com/news/?ticker=THCX.V

On Tuesday, shares of VentriPoint Diagnostics recorded a trading volume of 35,000 shares, which was below the three months average volume of 298,148 shares. The stock ended the day flat at 0.30. The share price has gained 76.47% from its 52-week low with a 52-week trading range of 0.17 - 0.55. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.32 is greater than its 200-day moving average of $0.27. Shares of VentriPoint Diagnostics have fallen approximately 3.23 percent year-to-date.

Access RDI’s VentriPoint Diagnostics Ltd. Research Report at:
https://rdinvesting.com/news/?ticker=VPT.V

Our Actionable Research on RNC Minerals (TSX:RNX.TO), Delivra Corp. (TSXV:DVA.V), The Hydropothecary Corp. (TSXV:THCX.V) and VentriPoint Diagnostics Ltd. (TSXV:VPT.V) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com